Bearish flow noted in Cytokinetics (CYTK) with 1,256 puts trading, or 1.6x expected. Most active are Jun-26 55 puts and May-26 35 puts, with total volume in those strikes near 870 contracts. The Put/Call Ratio is 3.95, while ATM IV is up nearly 32 points on the day. Earnings are expected on May 6th.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYTK:
- Insiders Cash Out: Cytokinetics, Itau, ASE, Clene, Black Stone
- Cytokinetics initiated with an Overweight at Wells Fargo
- Cytokinetics management to meet with Citizens
- Cytokinetics price target raised to $95 from $87 at Barclays
- MYQORZO’s Differentiated Superiority in oHCM and De‑Risked Pipeline Support Buy Rating on CYTK